According to data from eToro, leading the list was telehealth platform, Hims & Hers Health, which surged 85 per cent in ...

WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women ...

Ford CEO Jim Farley made a bold prediction about the impact of AI on the white-collar workforce. How should investors prepare ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Rush will charge patients $19 per month or $189 per year for the service. It is among the first incumbent health systems to launch its own subscription direct-to-consumer platform, joining a crowded ...

NEW YORK (Reuters) -WeightWatchers will announce on Tuesday Dr. Kim Boyd as its chief medical officer, and plans for a new program to help women manage the transition into menopause and beyond, part ...

RBC, BMO and Bank of Nova Scotia – will compel employees to return to the office at least four days a week. That’s currently ...

Several stocks – NVIDIA NVDA, Palantir PLTR, and Amazon AMZN – continue to garner significant attention among investors, with ...

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

A high-level overview of Hims & Hers Health, Inc. (HIMS) stock. View (HIMS) real-time stock price, chart, news, analysis, analyst reviews and more.